Detalhe da pesquisa
1.
Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs.
Glia
; 72(5): 872-884, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258347
2.
Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 204(4): 1393-1401, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168845
3.
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
J Intern Med
; 295(2): 216-228, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899297
4.
Effects of fluorescent protein tdTomato on mouse retina.
Exp Eye Res
; 243: 109910, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663720
5.
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
J Intern Med
; 293(3): 329-339, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284445
6.
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.
Am J Hematol
; 89(2): 130-6, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122923
7.
Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.
Cancer Med
; 13(4): e7074, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457215
8.
REG1A protects retinal photoreceptors from blue light damage.
Ann N Y Acad Sci
; 1527(1): 60-74, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531162
9.
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
J Hematol Oncol
; 16(1): 42, 2023 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120593
10.
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial.
J Clin Oncol
; 41(29): 4632-4642, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335960
11.
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial.
J Clin Oncol
; 41(2): 343-353, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084276
12.
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study.
Signal Transduct Target Ther
; 8(1): 348, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704613
13.
Functional microglia derived from human pluripotent stem cells empower retinal organ.
Sci China Life Sci
; 65(6): 1057-1071, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451725
14.
Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?
Front Immunol
; 13: 1036403, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36389692
15.
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow Grafts.
Transplant Cell Ther
; 28(12): 849.e1-849.e8, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049734
16.
Frequent recurrence of pregnancy-triggered congenital thrombotic thrombocytopenic purpura: A rare case report.
Clin Hemorheol Microcirc
; 77(2): 195-200, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925004
17.
Neutrophil CD64: a potential biomarker for the diagnosis of infection in patients with haematological malignancies.
Hematology
; 26(1): 970-975, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871536
18.
Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemia.
Cancer Lett
; 510: 59-66, 2021 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901594
19.
Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.
JAMA Netw Open
; 4(7): e2115991, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232303
20.
Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes.
Blood Cancer J
; 11(12): 195, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873148